Shenol, Aslihan
Tenente, Ricardo http://orcid.org/0000-0002-7970-278X
Lückmann, Michael
Frimurer, Thomas M. http://orcid.org/0000-0002-9682-8245
Schwartz, Thue W. http://orcid.org/0000-0002-0261-6904
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18CC0034900, NNF23SA0084103, NNF15CC0018346)
Article History
Received: 25 March 2024
Accepted: 6 June 2024
First Online: 25 June 2024
Competing interests
: TWS and TMF are co-founders of SOLID Therapeutics and TWS is co-founder of Embark Biotech and TMF of Ankrin Therapeutics. All other authors declare no competing interests.